Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 28-sep-2026 · last seen 28-sep-2026

AEP Inhibitors (CP#11A)

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-09-16 — Endothelial C/EBPβ/AEP pathway drives vascular deterioration and systemic aging.: Mouse study: endothelial C/EBPβ/AEP activation cleaves NAMPT and depletes systemic NAD+, driving vascular deterioration, senescence, and shortened lifespan; genetic or pharmacologic AEP inhibition with CP#11A rescued vascular aging and outperformed NMN — preclinical only, no human data. [animal-model] (novelty: 4)

Open questions

Related

Contributing findings

pubmed preclinical animal-model
Endothelial C/EBPβ/AEP pathway drives vascular deterioration and systemic aging.
16-sep-2026 novelty 4 per-area 4 strengthens

build build 880 · 2bcef25 · 2026-11-18